Compare CNVS & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNVS | ZTEK |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.1M | 59.5M |
| IPO Year | 2016 | 2022 |
| Metric | CNVS | ZTEK |
|---|---|---|
| Price | $2.40 | $0.55 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 189.0K | 142.1K |
| Earning Date | 02-17-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $84.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.77 | $0.37 |
| 52 Week High | $6.25 | $1.24 |
| Indicator | CNVS | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 62.56 |
| Support Level | $2.34 | $0.55 |
| Resistance Level | $2.65 | $0.75 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 13.56 | 83.85 |
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
Zentek Ltd is engaged in developing opportunities in the graphene and related nano-materials industry based on its intellectual property, patents, and Albany graphite. The Company's operating segments are Intellectual Property Development, Biotech, and Albany Project. Intellectual Property Development includes the manufacturing and distribution of graphene-related products. Biotech includes service revenue generated through aptamer technology. The Albany Project includes the exploration and evaluation of assets and mineral exploration activities.